MedPath

The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients

Phase 3
Recruiting
Conditions
Antibiotic Prophylaxis
Wound Infection
Groin Hernia
Interventions
Registration Number
NCT06576154
Lead Sponsor
University of Aleppo
Brief Summary

This study aims to investigate the impact of antibiotic prophylaxis on reducing wound infection rates following open repair of primary elective groin hernias in high-risk patients.

Detailed Description

This study will be a randomized controlled trial involving high-risk patients undergoing open repair of primary elective groin hernias. Participants will be randomized into two groups: one receiving antibiotic prophylaxis and the other serving as the control group. The study will assess the incidence of wound infections postoperatively in both groups to determine the effectiveness of antibiotic prophylaxis in lowering infection rates.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Volunteer to participate in the study.
  • Elderly patients aged over 60 years.
  • Patients with Diabetes.
  • Or obese patients with a BMI greater than 35.
  • Or immunocompromised patients.
  • Or American Society of Anesthesiologists (ASA) physical status classification 2 or more, with a history of more than 10 years.
Exclusion Criteria
  • Non-cooperative patients for regular follow-up.
  • Therapeutic Indication for.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Prophylaxis antibiotics GroupCefazolin 1000 MGPatients with Antibiotic Prophylaxis post-open Repair of Primary Elective Groin Hernias in High-Risk Patients.
Primary Outcome Measures
NameTimeMethod
Overall Complication Rateup to 30 days after the surgery.

Overall complication rate; graded by the Clavien- Dindo complications classification system

Wound infection/ Surgical site infectionup to 30 days after the surgery.

has been defined and classified as superficial incisional, deep incisional, and organ/ space_ surgical site infection by the Centers for Disease Control and Prevention (CDC) (Anderson 2014; Ban 2017; Berríos-Torres 2017).

Secondary Outcome Measures
NameTimeMethod
Hospital stayup to 30 days after the surgery.

In days: Number of days, patient in hospital since admission.

Mortality Rateup to 30 days after the surgery.

The measure of the number of deaths at the end of the study.

Trial Locations

Locations (1)

Aleppo University Hospital

🇸🇾

Aleppo, Syrian Arab Republic

© Copyright 2025. All Rights Reserved by MedPath